A Study to Learn More About How Safe Darolutamide is Under Real-world Conditions in Participants With Metastatic Hormone-Sensitive Prostate Cancer
Condition: Metastatic Hormone-sensitive Prostate Cancer (mHSPC) Intervention: Other: No Intervention Sponsor: Bayer Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Hormones | Learning | Prostate Cancer | Research | Study | Universities & Medical Training